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EDITORIAL
Establishing Cancer Units
RA Haward
Yorkshire Cancer Organisation. .4rthington House. Cookridge Hospital, Leeds LS16 6QB. L-K.
Summarv The creation of effective cancer units is central to the implementation of the report .4 Polici
Framework for Commissioning Cancer Seriices. produced by the Chief Medical Officers of England and Wales.
recently issued by the Department of Health in April 1995. While cancer um'ts are described in this report a
range of important questions remain about their nature and how they should be developed. This paper
addresses these issues in three ways. A definition of the cancer unit is suggested and its main implications spelt
out. The problems of establishing cancer units are covered under three headings. Where should cancer units
be? Which cancer sites should the unit cover? What is needed to establish the cancer unit? Finally two
checklists are presented. describing the task from the perspectives of the distnrct health authority and
hospital(s) concerned. The underlying theme is that real changes in clinical practice and orgamsation are the
goal. and these can onlv be achieved where there is extensive local dialogue in which the relevant issues are
addressed in a structured and rigorous manner. Cosmetic changes in hospital designation Will not achieve the
consistent quality of cancer service that is the cornerstone of the 'Calman' policy.
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The report produced by the Expert Advisory Group on
Cancer (EAGC; 1995) chaired by the Chief Medical Officer
(CMO) offers a clear policy framework. It sets out principles
to shape the way services are developed. It seeks to achieve
consistency in the delivery of cancer services across England
and Wales through the adoption of a common structure
based on three key elements: primary care: cancer units: and
cancer centres. Implementation of this policy is envisaged as
a devolved process. with much of the important detail to be
worked out on a local basis.
The National Health Service (NTHS) Executive has
endorsed the policy after only minor modifications to the
consultative text. although their approach to issues such as
resources. timescales. and priority are yet to be clarified.
Important questions of manpower supply and training are
also in urgent need of clear direction. Some of the underlying
issues which the policy sought to address are of immediate
concern. and in many parts of the country the 'Calman'
approach is beginning to be adopted. Many of the regions
have established working parties to take thinking forward in
advance of a formal obligation to do so. This is a gratifying
response to a consultation document and implies recognition
of the weaknesses in cancer services which the CMO set out
to address. These early moves to consider the adoption of the
approach have exposed uncertainties about how it can best
be implemented. The EAGC had sought to offer a
framework. avoiding a highly prescriptive model which took
no account of relevant circumstances. However questions are
now arising about both the nature of cancer units and the
means by which they should be established. which may de-
tract from what is otherwise a constructive debate.
The establishment of cancer units lies at the heart of the
successful application of the policy. and confusion on this
question may reinforce anxieties in hospitals about what the
policy might mean. This paper seeks to address this uncer-
tainty by offering some thinking on three aspects. First it
suggests a working definition of the cancer unit, it then sets
out a framework for district health authorities. trusts and
involved clinicians to use in working towards their creation.
and finally offers checklists for some of their roles and func-
tions.
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Definition
Cancer units are described rather than defined in the consult-
ation document. It may therefore be helpful to define a
cancer unit. and the following is suggested:
A cancer unit is either a single hospital. or two or
more hospitals working to a common agenda. which
both district health authority and trust(s) agree to be
capable of managing patients presenting with a defined
range of cancers to contemporary standards of good
practice. or of so doing within a finite development
period.
NOTE: Managing is intended to include appropriate
referrals for specific clinical purposes to a cancer cen-
tre.
This definition introduces four distinct elements which must
be dealt with in any proposal to constitute a cancer unit:
(1) A cancer unit may comprise two or more hospitals
working together. in which case the question as to how-
that is to be achieved must be satisfactorily addressed.
(2) There must be an agreement defining the range of
cancer sites for which services are to be provided.
(3) The establishment of cancer units is a prospective proc-
ess which requires the introduction of changes in
clinical organisation and practice within a set time-
scale.
(4) Services offered by units should reach identified stand-
ards. such as conforming to established guidelines
(where these exist and are applicable). meeting equiv-
alent locally produced specifications or participating in
externally run audit programmes.
The process of establishing cancer units is not simply an
exercise in the rebadging of existing institutions. There is no
quota governing the numbers of units which can be created.
Under the definition suggested. existing hospitals providing
cancer services have the option of exploring the implications
of the policy with their district health authorities (DHAs) in
the light of their expertise and aspirations. The scope for
collaborative arrangements between neighbounrng trusts is
considerable, although the mechanisms for this will require
managenal innovation and a partnership rather than com-
petitive ethos.Estalig cancer units
RA Haward
Creating cancer units
There are three essential questions to be faced by DHAs and
trusts in resolving the location and nature of cancer units.
Where should they be? Which fields should they cover? What
is needed to establish them?
Where should cancer units be?
Decisions on location will inevitablv have to take a range of
issues into account. Past Health Service policy has located
many cancer serVices within district hospitals serving popula-
tions as small as 100 000 rising to over 500 000. Fresh think-
ing is going to be required in considering the future cancer
unit pattern. Important issues will include: patient access:
local attitudes. including those of general practitioners; the
level of local clinical interest and expertise; the potential
volumes of work (by cancer site): the case for greater cancer
specialisation and its impact on other hospital services; and
the efficiency of the resulting service. For purchasers and
providers there will be obvious contractual implications, not
the least of which is cost.
Similar considerations apply to other services too, for
example. major trauma. care of neonates. and vascular
surgery. issues which clearly interact one with another. It is
important however. that for cancer services the principle set
out in the EAGC report of uniform access to high quality
services is paramount. Too many concessions to local vested
interest may compromise that principle and weaken the
ability of the aspirant unit to meet the standards likely to be
expected. perpetuating existing inadequacies in services.
Which cancer sites should the unit cover.9
The essential criterion here has to be that units only deal
with cancer sites for which they have the capability. both in
expertise and facilities.
Large variations in survival (Berino et al.. 1995: Sainsbury
et al. 1995a) and in the deployment of cancer treatments
abound. There is also growing evidence of the existence of
relationships between specialisation. caseload and outcome
(Kramer et al.. 1984: Matthews et al.. 1986: Davis et al..
1987: Stiller. 1988: Luft et al.. 1990: McArdle and Hole.
1991: Stiller 1994: Sainsbury et al.. 1995b). although these
relationships are proving hard to quantify. It may therefore
be unrealistic to expect precise guidance setting minimum
workloads for every form of cancer treatment, creating arbit-
rarv distinctions between what is acceptable and unaccep-
table which are not justified by evidence. The status quo
however, is not a tenable position as there is still too much
fragmentation of cancer work between consultants, and
single-handed clinical decision-making where a range of disc-
iplines ought to be involved. The determining factor as to
what is done where. may ultimately be the economic realities
of properly applying site specialisation amongst surgeons and
adopting genuinely multidisciplinary. multimodality manage-
ment. These arrangements will be uneconomic for low
numbers of cases.
The report of a working party of the British Breast Group
(1995) bravely contributes their view on numbers to this
dialogue bv suggesting a working minimum of 75 new cases
per year for their model breast service, although their stated
preference is for 100 new cases. But for the most part there
are only general principles about what workload might be
consistent with a 'practice makes perfect philosophy' avail-
able to guide aspirant units at the present time.
It is possible to suggest some stratification of cancer sites
based on their incidence, although there is considerable room
for debate about the optimum location of services for some
sites. Most district hospitals will have sufficient caseload to
give them the potential to manage four common cancers.
These are breast (approximately 55 new cases per 100 000
population per year). colorectal (approximately 55 new cases
per 100 000 population per year). lung (approximately 75
new cases per 100 000 population per year) and skin (approx-
imately 65 new cases per 100 000 population per year) exc-
luding melanoma. Where they have the expertise. medium-
sized cancer units. whether single hospitals or smaller hos-
pitals acting together. can expect to make additions from the
following list of more intermediate cancers. These can be
defined somewhat arbitrarily as covering those cancer sites
with between 8 and 30 new cases per 100 000 population per
year. although in situ carcinoma of the cervix has a higher
incidence (approximately 40 new cases per 100000 popula-
tion per year). This list includes pancreas. stomach. bladder.
kidney. prostate. cervix. ovary. uterus. as well as some
haematological malignancies and melanoma. However, both
the complexities of management and the nature of treatment
needs for many of these cancer sites suggests that some
limitations should be accepted by units in the extent of their
clinical roles, reflecting working agreements as to which cases
ought to be referred to the cancer centre. Taking carcinoma
of the pancreas as an example. there is a proportion. perhaps
as high as 20% of cases, in which early diagnosis leading to
potentially curative surgery may be possible. In ovarian
cancer. management is frequently concerned with the selec-
tion and delivery of an appropriate sequence of
chemotherapy. tailored to the status of the patient and stage
of the tumour. These issues exemplify clinical policy issues
that need debate if appropriate distinctions are to be made
between unit and centre roles.
Cancer centres. and exceptionally for one or two of these
cancer sites some of the largest units. should expect to deal
with all or most of the following: bone, central nervous
system, head and neck, primary liver tumours, oesophagus,
soft tissue sarcomas, germ cell tumours. childhood and
adolescent cancers, plus rare and complex diseases. Geso-
phagus excepted, these cancers occur in small numbers below
a threshold of 8 new cases per 100 000 population per year.
The perhaps controversial case for putting oesophageal
cancer in the cancer centre/largest unit group reflects a curr-
ent pattern of widely distributed and variable practice. with
generally poor results. Disentangling these issues will become
clearer as considered professional guidance becomes available
from interested multidisciplinary groups. colleges and prof-
essional bodies.
What is needed to establish the cancer unit?
The key to successful progress lies in dialogue between the
principal parties. a process which has already begun in many
places, albeit tentatively. Those who must be involved are the
DHAs as a focus for purchaser perspectives within fundhold-
ing. as well as representing their statutory roles. trust man-
agement and relevant clinicians. The latter need to be drawn
into these discussions because their experience is essential if
site-specific services are to be addressed. These discussions
will address a number of matters:
(1) The range of cancer sites requiring consideration:
(2) Realistic options for service delivery and clinical organ-
isation for each:
(3) The necessary expertise skills that are required and how
shortfalls might be addressed:
(4) 'Whole hospital' cancer issues and how these are to be
resolved;
(5) The impact of greater specialisation in cancer treatment
on the delivery of other services;
(6) Facilities and accommodation necessary to provide the
services;
(7) Cost and timetable implications.
These issues emphasise the definition of a cancer unit which
presupposes that there will be an agreed but finite period
during which an existing hospital or group of hospitals
develop their service to achieve the desired level of perform-
ance. Once discussions covering these issues have been satis-
factorily completed, and agreed criteria satisfied, then a pro-
cess is required which will allow the parties concerned to
secure the designation of their cancer unit. This process of
designation ought to be based primarily on agreementE aishi- cancerunits
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between DHAs and the trusts concerned. Exceptionally it
may need to be resolved within a wider context, perhaps
through involvement of the regional tier. For a cancer unit to
be designated six important questions will need to have been
answered:
(1) Where are services for each of the main cancer sites to
be provided?
(2) What standards or local service specifications are to
apply?
(3) Have the development pathways and their timescales
been identified and agreed?
(4) Is there a shared understanding of contractual implicat-
ions, including cost?
(5) Are there the means of monitoring progress. perfor-
mance and outcomes?
(6) Has the relevant cancer centre or centres been ident-
ified?
The question of monitoring performance needs elaboration.
There is a strong case for ensuring that basic data is
accurately collected and marshalled. DHAs could. with
advantage, act together to require cancer units to make
available the stage of certain cancers consistently, in accord-
ance with protocols acceptable to clinicians, pathologists and
their cancer registry. The proportion of cancers staged and
histologically confirmed would be useful performance ind-
icators.
Individual measures will be needed for individual cancer
sites covering a range of caseload, treatment and outcome
data. Some measures should deal with the overall operation
of services encompassing relationships with general practices.
There is evidence. for example in some gastrointestinal malig-
nancies (Sue-Ling et al.,1992; Robinson et al.. 1993), that
the proportion of cases presenting with early stage disease
can be increased through a variety of measures. Thus over a
period of time the proportion of cases with early stage diag-
nosis becomes a performance measure, with a direct rele-
vance to outcome.
Audit is needed across a number of individual units in
order that results can be compared. This may either be
organised through the cancer centre or. where there are
established 'regional' or local professional groups with
interests in particular cancer sites, these could be used.
Effective cancer registries are an essential prerequisite for
comparative audits on a large scale. There are also moves
being made by those interested in some cancer sites to press
the merits of obligatory national audit, quality assurance.
and even accreditation of site-specific unit services.
The final element is entry into clinical trials. Trials provide
a means of quality assurance of those aspects of the treat-
ment and care covered by the trial protocols. Entry is
generally associated with good outcomes (Stiller. 1994).
Monitoring the range of trials into which patients are entered
and the proportion of eligible patients included is a valid
measure of performance.
Checklists for action
It is worth summarising in checklist form the main issues
which units need to consider, covering key roles and the
principle changes which need to be brought about.
The process ofestablishing cancer units faces DHAs with a
number of complex problems.
(1) The intention of the policy is to focus attention on the
operation of services as a whole.
(2) Their goal is the achievement of qualitative changes in
clinical practice and the organisation of services.
(3) It requires service issues for individual cancer sites to be
considered explicitly.
(4) The flexibility within the policy requires DHAs to adopt
an active role.
(5) There are shortfalls in some key inputs which need
addressing over time. with pressure for additional invest-
ment.
(6) Successful implementation will generate improvements
in cancer outcomes.
(7) Public interest is important. and likelv to be supportive
of qualitative improvements.
The cancer unit will be the focus for a range of important
external changes as well as those within the institution itself.
(1) Building links with general practices to clanrfy arrange-
ments for referral and diagnosis. including professional
education, defining appropriate referrals and com-
munications.
(2) The development of improved and properly co-ordin-
ated diagnostic arrangements for dealing with relevant
common symptomatology.
(3) Site specialist surgeons covering those cancer sites in
which surgery is the prime form of management.
(4) Multimodality therapy in which the selection and man-
agement of patients is undertaken on a multidisciplinarv
basis.
(5) The enhancement of staffing in non-surgical oncology to
at least the Calman' standard.
(6) Co-ordination of cancer care and treatment within the
hospital. with a lead clinician.
(7) Comprehensive psychosocial support to patients and
carers. and palliative care arrangements linking
effectively with community and voluntary sector ser-
vices.
(8) Clear arrangements for the management of patients
between unit and centre and for audit.
Conclusion
The process of establishing cancer units should build on the
consultation document and set implementation writhin a local
context. Responsibility for creating cancer units lies between
DHAs and trusts. The designation of cancer units is a logical
consequence of the process of developing cancer services in
accordance with the policy. The approach suggested recog-
nises that cancer services are complex to provide and that the
chief role for DHAs is to achieve qualitative improvements.
There are real shortcomings in the quality of cancer care as
presently delivered within the UK if international com-
parisons such as the Eurocare Study are to be believed.
Change requires a preoccupation with the achievement of
consistent high standards of practice which are carefully
monitored.
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